Fizzy drinks are the new tobacco and Coca-Cola should be banned from sponsoring the Olympics. My piece in the Mail+ about why I am supporting the #KickBigSodaOutofSport campaign. Please share and sign the petition here kickbigsodaout.org/#petition dailymail.co.uk/health/article…

The socioeconomic gradient of health in Australia is the biggest problem we face in healthcare. Being poor costs around a decade of good health.

The commercial indeterminants of health

Older adults are making up a rising number of trauma patients. Collaboration between geriatricians and trauma surgeons means we all bring our different skills to help complex patients and to get the expertise of both teams. injuryjournal.com/article/S0020-…

When you realise all of these women will be judged harshly by society for what they’re wearing and their bodies critiqued you truly understand how it’s impossible for women to win.

“Available data do not confirm that lecanemab and donanemab are disease-modifying.” #Alzheimers #endalz alz-journals.onlinelibrary.wiley.com/doi/full/10.10…

You know who else was a longevity bro…

Imagine if instead of big builds in random suburbs, the priority was social housing near existing infrastructure.

There is not an infinite pool of public dollars. A key principle of health economics is that money spent has to provide quality life years. If this is ignored, the entire health system falls apart.

All health journalists should be asking any researcher they speak to about sources of funding before deciding to quote them.

When you understand this question, screening for disease, looks dubious. So, now, you see why screening for disease is so popular

In geriatrics we get more training in these kids of conversations and maybe that is why we don’t tend to shy away. What this means is that so often, I meet someone for the first time and I am the first person to bring this up.

I was honoured to provide commentary on the issue of low falls for older adults and the role of the trauma geriatrician. …7-47a2-9d3b-6e1e004d120d.usrfiles.com/ugd/cef77c_9ee…

The benefit from the new lot of amyloid removing drugs are extremely small and come with significant risks and huge $ cost. I know that people who have invested many years in amyloid research want these drugs to be the cure, but the data simply does not support this.

Conflicts on interest in healthcare continue to adversely impact what we do. The coverage of lecanemab and NICE decision - look for undisclosed interests…. | Margaret McCartney | The Guardian theguardian.com/commentisfree/…

USA friends, I am thrilled to share that Before Dementia is available today! It has meant so much hearing from people who found this book when they needed it, and I am so glad it can reach a wider audience.

Some important points to note when reading stuff suggesting Elle Macpherson "treated" herself with a "heart-led, holistic approach" to #breastcancer. 1) One patient does not evidence make. smh.com.au/lifestyle/heal…

A JAMA article titled “The Latest Research About Paxlovid” has a surprising but very expected omission in the summary of the evidence for Paxlovid: the lack of any discussion of the negative EPIC-SR study. jamanetwork.com/journals/jama/… A 🧵on why we keep seeing this omission (1/10)